PEDs Drug Quiz 1

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/69

encourage image

There's no tags or description

Looks like no tags are added yet.

70 Terms

1
New cards

Types of surfactants

-animal-derived

-synthetic-derived

2
New cards

Surfactant drug name endings

-acant

3
New cards

What are surfactants used to treat?

Respiratory Distress Syndrome

4
New cards

Bonvine Lipid Extract Surfactant brand name

BLES

5
New cards

Bonvine Lipid Extract Surfactant indication

Respiratory distress syndrome in premature neonates

6
New cards

Bonvine Lipid Extract Surfactant dosing

< 380g and > 4,460g: Endotracheal: Administer 5mL/kg/dose as soon as RDS diagnosed

-may repeat dose if needed, up to a total of 4 doses within the first 5 days of life

7
New cards

Bonvine Lipid Extract Surfactant BW

temporary slow heartbeat and low oxygen levels may happen with this drug

8
New cards

Bonvine Lipid Extract Surfactant AE >10%

-Bradycardia

-patent ductus arteriosus

-sepsis

-intraventricular hemorrhage

-retinopathy of prematurity

-decreased lung function (decrease Osats or increase CO2)

9
New cards

Bonvine Lipid Extract Surfactant DDI

Bradycardia causing agents (camizestrant, ceritinib, estrasimod, fexinidazole, fingolimod, ivabradine, lacosamide, landiolol, midodrine, ozanimod, ponesimod, siponimod)

10
New cards

Bonvine Lipid Extract Surfactant MOA

Replaces deficient or ineffective endogenous lung surfactant in neonates with respiratory distress syndrome (RDS). Surfactant prevents the alveoli from collapsing during expiration by lowering surface tension between air and alveolar surfaces.

11
New cards

Bonvine Lipid Extract Surfactant CI

Hypersensitivity to bovine lipid extract surfactant or any component of the formulation; active pulmonary hemorrhage.

12
New cards

Bonvine Lipid Extract Surfactant pt counseling

1. Used to treat lung distress in premature babies

2. SE to call Dr: trouble breathing, signs of allergic rxn, signs of infection, coughing up blood, seizures, black, tarry, or bloody stools, wheezing, slow heartbeat

3. The drug is given into the lungs with a tube

13
New cards

Beractant brand name

Survanta

14
New cards

Beractant drug class

lung surfactant

15
New cards

Beractant indication

RDS

16
New cards

Beractant dosage form

1mL of beractant contains 25mg of phospholipids

17
New cards

Beractant dosing

Rescue Tx Preterm neonates: endotracheal 4mL/kg following Dx of RDS

-Additional doses may be administered if patient remains intubated and requires at least 30% inspired fraction of oxygen (FiO2) to maintain adequate oxygenation

-Dosing more often than Q12H is typically not required unless surfactant is being inactivated by infectious process, meconium, or blood

-Doses should not be given more frequently than Q6H

-Up to 4 doses may be administered if evidence of respiratory distress continues.

Prophylactic therapy: routine prophylactic surfactant administration is no longer recommended

-Preterm neonates: endotracheal: 4mL/kg as soon as possible after birth, preferably within 15 minutes.

18
New cards

Caution with beractant

-Mucous plugs: Marked impairment of ventilation during or shortly after dosing may indicate mucous plugging of the endotracheal tube; suctioning all neonates prior to administration may decrease chance of endotracheal tube obstruction. Replace endotracheal tube immediately if obstruction is not removed with suctioning.

-Nosocomial sepsis: There is an increased risk of post-treatment nosocomial sepsis in treated neonates this increased risk was not associated with increased mortality.

-Transient adverse effects: Transient episodes of bradycardia and decreased oxygen saturation may occur. Discontinue dosing procedure and initiate measures to alleviate the condition; may reinstitute after the patient is stable. Rales and moist breath sounds may occur; endotracheal suctioning or other remedial action is necessary if clear-cut signs of airway obstruction are present.

-Intended for endotracheal administration only

-Use in neonates

-Lung oxygenation/lung compliance: Produces rapid improvements in lung oxygenation and compliance that may require frequent adjustments to oxygen delivery and ventilator settings; hyperoxia may occur within minutes of administration.

-Trained personnel: Rapidly affects oxygenation and lung compliance; restrict use to a highly-supervised clinical setting with immediate availability of clinicians experienced in intubation and ventilatory management of premature neonates.

19
New cards

AE beractant (>10%)

Bradycardia, hypertension, hypotension, vasoconstriction, pallor, oxygen desaturation, sepsis, intracranial hemorrhage, apnea, hypercapnia, low blood pCO2, pneumothorax, pulmonary emphysema

20
New cards

DDI of beractant

Drugs that cause bradycardia (camizestrant, ceritinib, estrasimod, fexinidazole, fingolimod, ivabradine, lacosamide, landiolol, midodrine, ozanimod, ponesimod, siponimod)

21
New cards

MOA of beractant

Replaces deficient or ineffective endogenous lung surfactant in neonates with respiratory distress syndrome (RDS) or in neonates at risk of developing RDS. Surfactant prevents the alveoli from collapsing during expiration by lowering surface tension between air and alveolar surfaces. /

22
New cards

Beractant counseling

1. Used to treat or prevent lung distress in premature babies

2. Call your doctor if you have signs of allergic reaction, trouble breathing, slow heartbeat, cough

3. This drug is given into the lungs with a tube /

23
New cards

Calfactant brand name

Infasurf

24
New cards

Calfactant drug class

lung surfactant

25
New cards

Calfactant dosage form

1mL of calfactant contains 35 mg phospholipid

26
New cards

Calfactant indication

RDS

27
New cards

Calfactant dosing

Rescue Tx: Newbowns

-additional doses may be administered if patient remains intubated and requires at least 30% inspired fraction of oxygen (FiO2) to maintain a PaO2 ≤80 torr

-dosing more often than every 12 hours is typically not required unless surfactant is being inactivated by an infectious process, meconium, or blood

-doses should not be given more frequently than every 6 hours

-up to 4 doses may be administered if evidence of respiratory distress continues

prophylactic therapy: routine prophylactic surfactant administration is no longer recommended

-Premature newborns (< 29 weeks gestation): endotracheal: 3mL/kg as soon as possible after birth, preferably within 30 minutes

28
New cards

Adminstration info of calfactant

Gently swirl vial to redisperse suspension; do not shake. Slowly draw dose into a syringe using a 20-gauge or larger needle taking care to avoid excessive foaming. Warming of vial prior to administration is not necessary.

29
New cards

Storage of calfactant

-store upright (3mL) and under refrigeration at 2C to 8C (36F to 46F)

-Protect from light

-Document date and time removed from refrigeration

-Unopened and unused vials of calfactant that have been warmed to room temp can be returned to refrigeration storage within 24 hours for future use; do not re-refrigerate more than one time.

-Discard unopened vials left at room temperature for >24 hours; discard unused portion after initial vial entry.

30
New cards

Caution with calfactant

-Transient AE: Transient episodes of bradycardia, decreased oxygen saturation, endotracheal tube blockage or reflux of calfactant into endotracheal tube may occur. Discontinue dosing procedure and initiate measures to alleviate the condition; may resume treatment with appropriate monitoring.

-For intracheal administration only

-Monitoring: Produces rapid improvements in lung oxygenation and compliance that may require frequent adjustments to oxygen delivery and ventilator settings.

-Trained personnel

31
New cards

AE (>10%) calfactant

bradycardia, endotracheal tube reflux, airway obstruction, cyanosis

32
New cards

Allergy with calfactant

calfactant allergy

33
New cards

Calfactant DDI

Drugs that cause bradycardia (camizestrant, ceritinib, estrasimod, fexinidazole, fingolimod, ivabradine, lacosamide, landiolol, midodrine, ozanimod, ponesimod, siponimod)

34
New cards

MOA of calfactant

Endogenous lung surfactant is essential for effective ventilation because it modifies alveolar surface tension, thereby stabilizing the alveoli. Lung surfactant deficiency is the cause of respiratory distress syndrome (RDS) in premature infants and lung surfactant restores surface activity to the lungs of these infants.

35
New cards

Counseling calfactant

-Used to treat or prevent lung distress in premature babies

-Call Dr if: signs of allergic reaction, trouble breathing new or worse, blue/gray skin color, slow heartbeat, seizures

36
New cards

Poractant Alfa brand name

Curosurf

37
New cards

Drug class of poractant alfa

lung surfactant

38
New cards

Indication of poractant alfa

RDS

39
New cards

Dosage form of poractant alfa

1mL of poractant alfa contains 76 mg of phospholipids

40
New cards

Dosing of poractant alfa

Preterm neonates: endotracheal: initial 2.5mL/kg/dose following a Dx of significant RDS

If pt remains intubated and continues to require oxygen to maintain adequate oxygenation, may administer 1.25 mL/kg/dose at 12-hour intervals for up to 2 additional doses.

41
New cards

What is the INSURE technique?

INtubate-SURfactant-Extib

42
New cards

Less invasive methods of surfactant administration poractant-alfa

-Minimally invasive surfactant therapy (MIST)/less invasive surfactant administration (LISA): Limited data available; optimal dose not established

-Preterm neonates: intratracheal: 1.25 to 2.5 mL/kg/dose; dosing based on trials that included infants with GA 24 to < 36 weeks; most studies allowed for repeat doses of 1.25 mL/kg if progressive RDS symptoms were noted and/or FiO2 ≥30%

-Laryngeal mask airway (LMA): Preterm neonates weighing ≥1 kg: Intratracheal: 2.5 mL/kg/dose administered in 1 to 2 mL aliquots; dosing from trials that included infants with GA 28 to <36 weeks; a repeat dose may be administered if progressive RDS symptoms and/or increased FiO2 requirements are noted

43
New cards

Caution with poractant-alfa

-Pulmonary hemorrhage: Pulmonary hemorrhage is a known complication of premature birth and very low birth-weight. It has been reported in both clinical trials and postmarketing reports in infants who have received poractant alfa.

-Transient AE: Transient episodes of bradycardia, decreased oxygen saturation, hypotension, or endotracheal tube blockage may occur.

-Discontinue dosing procedure and initiate measures to alleviate the condition; may reinstitute after the patient is stable.

-Administration: for intratracheal administration only

-Monitoring: Produces rapid improvements in lung oxygenation and compliance; may require frequent adjustments to oxygen delivery and ventilator settings.

-Trained personnel: Rapidly affects oxygenation and lung compliance; restrict use to a highly-supervised clinical setting with immediate availability of clinicians experienced in intubation and ventilatory management of premature infants.

44
New cards

AE (>10%) of poractant alfa

patent ductus arteriosus, bradycardia, hypotension, oxygen desaturation, obstruction of endotracheal tube

45
New cards

DDI with poractant alfa

Drugs that cause bradycardia (camizestrant, ceritinib, estrasimod, fexinidazole, fingolimod, ivabradine, lacosamide, landiolol, midodrine, ozanimod, ponesimod, siponimod) /

46
New cards

MOA of poractant alfa

Endogenous pulmonary surfactant reduces surface tension at the air-liquid interface of the alveoli during ventilation and stabilizes the alveoli against collapse at resting transpulmonary pressures. A deficiency of pulmonary surfactant in preterm infants results in respiratory distress syndrome characterized by poor lung expansion, inadequate gas exchange, and atelectasis. Poractant alfa compensates for the surfactant deficiency and restores surface activity to the infant's lungs. It reduces mortality and pneumothoraces associated with RDS.

47
New cards

Counseling of poractant alfa

1. It is used to treat or prevent lung distress in premature babies.

2. Call Dr if: signs of allergic reaction, slow heartbeat, very bad dizziness or passing out

48
New cards

What drugs are antenatal corticosteroids?

-betamethasone

-dexamethasone

49
New cards

What does antenatal mean?

relating to the period of time before birth while a woman is pregnant

50
New cards

Who is given antenatal corticosteroids?

Mom

51
New cards

Betamethasone brand name

-Beta 1 Kit

-Celestone Soluspan

52
New cards

Betamethasone drug class

corticosteroid systemic

53
New cards

Betamethasone indication

pregnant women at risk of preterm birth to accelerate fetal lung maturity and reduce neonatal respiratory distress syndrome

54
New cards

Betamethasone dosing

12 mg IM every 24 hours for a total of 2 doses

55
New cards

When is a single course of betamethasone recommended?

patients between 24 to 34 weeks gestation, including those with ruptured membranes or multiple gestations, who are at risk of delivering within 7 days.

56
New cards

A single repeat course of betamethasone may be considered in some pts with:

pregnancies less than 34 weeks' gestation at risk for delivery within 7 days and who had a course of antenatal corticosteroids >14 days prior

57
New cards

Betamethasone administration

intramuscular route as part of a standard clinical course to promote fetal lung maturation. Shake well prior to use.

58
New cards

Betamethasone AE (>10%)

-CV: bradycardia, cardiac arrhythmia, cardiomegaly, circulatory shock, edema, embolism, HTN, hypertrophic cardiomyopathy

-Derm: acne, allergic dermatitis

-Endocrine: Cushing syndrome

-GI: abdominal distention, change in bowel habits, hiccups, increased appetite

-GU: bladder dysfxn, glycosuria, spermatozoa disorder

-Heme/onc: petechia

-Hepatic: hepatomegaly

-Infection

59
New cards

Betamethasone CI

hypersensitivity to any component of the formulation. IM administration contraindicated in immune thrombocytopenia (formerly known as idiopathic thrombocytopenic purpura)

60
New cards

Betamethasone MOA

Controls the rate of protein synthesis; depresses the migration of polymorphonuclear leukocytes, fibroblasts; reverses capillary permeability and lysosomal stabilization at the cellular level to prevent or control inflammation

61
New cards

Betamethasone DDI

Abrocitinib, aldesleukin, Allogeneic Regulatory T Cell Immunotherapy with HSPC and T Cells, Baricitinib, BCG products, brivudine, CAR-T Cell Immunotherapy, live vaccines, Cladribine, Coccidioides immitis Skin Test, COVID-19 Vaccine (mRNA), Delgocitinib, denosumab, desmopressin, immune checkpoint inhibitors, macimorelin, mifamurtide, mifeprostone,

62
New cards

Betamethasone patient counseling

1. It is used for many health problems like allergy signs, asthma, adrenal gland problems, blood problems, skin rashes, or swelling problems. This is not a list of all health problems that this drug may be used for. Talk with the doctor.

2. Call Dr if: upset stomach or throwing up, increased appetite, weight gain, restlessness, sweating a lot, hair thinning, trouble sleeping

63
New cards

Betamethasone caution

-High BP (very bad HA/dizziness/passing out)

-Infection

-High BG

-Cushing's syndrome like weight gain

-Weak adrenal gland

64
New cards

Dexamethasone brand name

Dexabliss, Dexylt, DoubleDex, Dxevo, Hemady, TaperDex

65
New cards

Dexamethasone drug class

Anti-inflammatory Agent; Antiemetic; Corticosteroid, Systemic

66
New cards

Dexamethasone indication

pregnant women at risk of preterm birth to accelerate fetal lung maturity and reduce neonatal respiratory distress syndrome, for pts between 24 to 34 weeks of gestation, including those with ruptured membranes or multiple gestations, who are at risk of delivering within 7 days.

67
New cards

Dexamethasone dosing

IM 6mg Q12H for a total of 4 doses

68
New cards

When is a single course of dexamethasone indicated?

22 weeks' gestation or late preterm (between 34 0/7 weeks' and 36 6/7 weeks' gestation) who are at risk of delivering within 7 days.

69
New cards

Dexamethasone administration

Administered via the intramuscular route as a clinical equivalent to betamethasone, often selected based on availability or cost considerations.

70
New cards

Dexamethasone pt counseling

take with meals to help prevent GI upset